MedTrace Logo

Biomarkers in Blood Samples From Older Breast Cancer Survivors

NCT01138345 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 246

Last updated 2014-02-27

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer. It may also help doctors understand how well patients respond to treatment.

PURPOSE: This research study is studying biomarkers in blood samples from older women with stage I, stage II, or stage III breast cancer who have finished primary therapy or breast cancer survivors.

Conditions

Interventions

GENETIC

gene expression analysis

blood samples will be analyzed for the expression of the p16 gene.

GENETIC

reverse transcriptase-polymerase chain reaction

perform reverse transcriptase-polymerase chain reaction on all blood samples.

OTHER

laboratory biomarker analysis

perform laboratory biomarker analysis on all blood samples

OTHER

medical chart review

perform medical chart review for all subjects

OTHER

questionnaire administration

each cohort will be given the same questionnaire

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • UNC Lineberger Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Hyman Muss, MD · UNC Lineberger Comprehensive Cancer Center

Eligibility

Min Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2013-01-31
Completion
2014-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01138345 on ClinicalTrials.gov